FSSAI warns about S-Adenosyl-L-Methionine (SAMe)
India
Oct 18, 2023
The Food Safety and Standards Authority of India (FSSAI) has issued a notification instructing all food safety enforcement authorities to take action in respect of products with S-Adenosyl-L-Methionine (SAMe) under FSSAI licence.
The FSSAI has made it clear that ingredients/products with S-Adenosyl-L-Methionine (SAMe) are not considered foods. Applications for approval of this compound as a "Health Supplement/Food for Special Medical Purpose (FSMP)/Food for Special Dietary Use (FSDU)" have consequently been rejected/revoked by the FSSAI.
For further information (in English), click on the Link
Phosphatidylserine (soy) authorized for use as a supplementary ingredient in foodstuffs
Canada
Apr 18, 2024
Nigeria/USA - Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison
Nigeria
Apr 17, 2024
FDA proposed to revise the standards for registration criteria and procedures for Health Supplements
Indonesia
Apr 17, 2024
CRN new guidelines for melatonin supplements and labeling of gummy supplements
USA
Apr 15, 2024
Guidelines on soy-derived phosphatidylserine food ingredients
Israel
Apr 15, 2024
New rules for dietary supplements handling companies in Michigan
USA
Apr 12, 2024
FDA warns about toxic yellow oleander in dietary supplements
USA
Apr 11, 2024
Algae list added to Germany's substances list
Germany
Apr 11, 2024
FDA Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements
USA
Apr 08, 2024
ANVISA updates regulation on food supplements
Brazil
Mar 08, 2024
TGA updates list of permissible ingredients in Therapeutic Goods
Australia
Mar 08, 2024
FDA new guidance on "New Dietary Ingredient Notification Procedures and Timeframes"
USA
Mar 03, 2024
ANVISA revises pre-market control system
Brazil
Feb 28, 2024
FDA updates directory of ingredients used in dietary supplements
USA
Feb 21, 2024
USA - A Review of Probiotic Ingredient Safety Supporting Monograph Development Conducted by the United States Pharmacopeia (USP)
USA
Feb 19, 2024
